Mesenchymal stem cells require MARCKS protein for directed chemotaxis in vitro

Area of Science:

• Stem cell biology
• Cellular and Molecular Medicine

Background:

• Mesenchymal stem cells (MSCs) are multipotent stromal cells found in various tissues.
• MSCs can differentiate into other cell types and circulate, with differentiated forms observed in lung tissue.
• MSC migration to injury sites is likely mediated by chemokine gradients.

Purpose of the Study:

• To investigate the role of myristoylated alanine-rich C kinase substrate (MARCKS) protein in the directed chemotaxis of bone marrow mesenchymal stem cells (BM-MSCs).

Main Methods:

• BM-MSCs were tested for chemotaxis towards specific chemokines (complement component 5a, stromal cell-derived factor-1alpha, monocyte chemotactic protein-1) using transwell inserts.
• Western blotting was used to detect MARCKS protein presence and phosphorylation in MSCs.
• The effect of a MARCKS-inhibiting peptide on BM-MSC chemotaxis was evaluated.

Main Results:

• BM-MSCs demonstrated directed chemotaxis towards increasing concentrations of tested chemokines.
• MARCKS protein was present and rapidly phosphorylated in BM-MSCs and human cord blood MSCs upon chemokine exposure.
• A MARCKS-inhibiting peptide significantly attenuated BM-MSC chemotaxis in a concentration-dependent manner, while a control peptide had no effect.

Conclusions:

• MARCKS protein plays a significant role in mediating the directed chemotaxis of bone marrow mesenchymal stem cells in vitro.
• These findings elucidate a novel mechanism regulating MSC migration, potentially impacting regenerative medicine strategies.